johns hopkins Sidney Kimmel Comprehensive Cancer Center - Cancer Science


The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center is a leading institution in cancer research, treatment, and education. Located in Baltimore, Maryland, it is part of the Johns Hopkins Medicine network and is renowned for its dedication to pioneering cancer care and innovative research.

What Makes the Sidney Kimmel Comprehensive Cancer Center Stand Out?

One of the key aspects that distinguish the Sidney Kimmel Comprehensive Cancer Center is its designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI). This title is awarded to centers that demonstrate excellence in clinical services, research, and education. The center is recognized for its multidisciplinary approach, bringing together teams of specialists to provide personalized treatment plans for each patient.

What Types of Cancer Treatments Are Offered?

The center offers a wide range of cancer treatments, including surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapies. These treatments are often combined in a multidisciplinary approach to provide the most effective care possible. The center is also at the forefront of developing new therapies and conducting clinical trials that offer patients access to cutting-edge treatments that may not be available elsewhere.

How Does the Center Contribute to Cancer Research?

Research is a cornerstone of the center's mission. The Sidney Kimmel Comprehensive Cancer Center conducts extensive research into the causes of cancer, its prevention, and its treatment. Researchers at the center are involved in basic science research, translational research, and clinical research, with a focus on understanding the mechanisms of cancer and developing new therapies. The center's collaboration with other research institutions and its use of advanced technologies support its role as a leader in cancer research and innovation.

What Educational Opportunities Does the Center Provide?

The center is also dedicated to education and training. It offers educational programs for medical students, residents, fellows, and practicing healthcare professionals. These programs ensure that the next generation of oncologists and researchers are well-equipped with the knowledge and skills necessary to continue the fight against cancer. Additionally, the center provides resources and support for patients and their families to help them understand their diagnosis and treatment options.

How Does the Center Support Patients and Families?

The Sidney Kimmel Comprehensive Cancer Center understands the impact of cancer on patients and their families. It offers a range of support services designed to address the emotional, psychological, and social needs of patients. These services include counseling, support groups, nutritional guidance, and integrative medicine therapies. The center's patient-focused approach ensures that care is comprehensive and compassionate, helping to reduce the stress associated with cancer diagnosis and treatment.

What Role Does Technology Play at the Center?

Technology is an integral part of the center's efforts to improve cancer care. The use of advanced diagnostic tools, such as genomic sequencing and imaging technologies, enables more accurate diagnosis and personalized treatment plans. The center also employs precision medicine approaches to tailor treatments based on the genetic makeup of both the patient and the tumor, increasing the likelihood of successful outcomes.

Can You Participate in Clinical Trials at the Center?

Yes, the Sidney Kimmel Comprehensive Cancer Center is actively involved in numerous clinical trials, offering patients the opportunity to participate in studies that explore new treatments and therapies. These trials are essential for advancing cancer treatment and often provide patients with access to the latest innovations in care before they become widely available.

How Can You Access Care at the Center?

Patients can access care at the Sidney Kimmel Comprehensive Cancer Center by obtaining a referral from their primary care physician or by contacting the center directly to schedule an appointment. The center accepts a wide range of insurance plans and provides financial counseling to assist patients in navigating the costs associated with cancer treatment. By reaching out to the center, patients can begin their journey to receive world-class cancer care.



Relevant Publications

Commentary on: \"Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial.\" Kwon ED, Drake CG, Scher HI, Fizazi K, Bossi A, van den Eertwegh AJ, Krainer M, Houede N, Santos R, Mahammedi H, Ng S, Maio M, Franke FA, Sundar S, Agarwal N, Bergman AM, Ciuleanu TE, Korbenfeld E, Sengeløv L, Hansen S, Logothetis C, Beer TM, McHenry MB, Gagnier P, Liu D, Gerritsen WR, CA184-043 Investigators. Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA, Electronic address: kwon.eugene@mayo.edu; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA; Institut Gustave Roussy, University of Paris-Sud, Villejuif, France; Institut Gustave Roussy, Villejuif, France; VU University Medical Centre, Amsterdam, Netherlands; Vienna General Hospital, Medical University Vienna, Vienna, Austria; Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France; Centro Médico Austral, Buenos Aires, Argentina; Centre Jean Perrin, Clermont-Ferrand, France; St John of God Hospital, Subiaco, WA, Australia; University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy; Hospital de Caridade de Ijuí, Ijuí, Brazil; Nottingham University Hospital, Nottingham, UK; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania; Hospital Británico de Buenos Aires, Buenos Aires, Argentina; Herlev Hospital, Herlev, Denmark; Odense University Hospital, Odense, Denmark; University of Texas MD Anderson Cancer Center, Houston,

Issue Release: 2015

Issue Release: 2015

Partnered Content Networks

Relevant Topics